Form 8-K - Current report:
SEC Accession No. 0001562762-24-000055
Filing Date
2024-03-14
Accepted
2024-03-14 16:17:22
Documents
14
Period of Report
2024-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8K 20240313.htm   iXBRL 8-K 37957
  Complete submission text file 0001562762-24-000055.txt   159049

Data Files

Seq Description Document Type Size
2 EX-101.SCH vaxx-20230922.xsd EX-101.SCH 1934
3 EX-101.LAB vaxx-20230922_lab.xml EX-101.LAB 15603
4 EX-101.PRE vaxx-20230922_pre.xml EX-101.PRE 11205
16 EXTRACTED XBRL INSTANCE DOCUMENT 20240313_htm.xml XML 4170
Mailing Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953
Business Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953 (254) 244-5739
Vaxxinity, Inc. (Filer) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41058 | Film No.: 24750392
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)